Merus N.V.’s Post

🌡️ Heat waves are no joke! As we face scorching temperatures, it's crucial to stay vigilant and be aware of the signs of heat stroke. At TupeloLife Digital Therapeutics, our clinical care team always keeps this in mind when monitoring our patients with chronic conditions. Remember, remote patient monitoring services can virtually help keep you safe and healthy during these challenging times. Stay cool, hydrated, and prioritize your well-being. ☀️💪 #HeatWaveSafety #StayCool #TupeloLifeDigitalTherapeutics #remotepatientmonitoring #chroniccaremanagement #tupelolife

The clinical evidence base for our covered #stent PK Papyrus continues to grow. In a systematic review and pooled analysis, patients treated with #PKPapyrus showed significantly less occurrence of In-Stent Restenosis (ISR) than patients treated with pericardial covered stents. What would you choose? ➡️ https://ow.ly/5jHf50PQ3FB #BIOTRONIK #PKPapyrus #WhatWouldYouChoose

PCR Perspectives: The bicuspid aortic valve is a real challenge in terms of diagnosis and treatment of patients, given that there are different phenotypes and patterns of calcification. View this discussion between Didier Tchetche and Raj Makkar to find out about patient selection criteria and more! https://lnkd.in/dSdsxZGg #TAVI #TAVR #EuroPCR #aorticvalve

Research is underway for #RSD #CRPS #CPS #Algoneurodystrophy, allowing you to be your best advocate for future diagnostics & treatments. If you are a patient interested in participating in a clinical trial, email [email protected] to join the list of interested patients

Research is underway for #RSD #CRPS #CPS #Algoneurodystrophy, allowing you to be your best advocate for future diagnostics & treatments. If you are a patient interested in participating in a clinical trial, email [email protected] to join the list of interested patients

Learn about the most current real-world evidence, clinical trial data and ongoing clinical trial programs for BTK inhibitors in the treatment of CLL/SLL. Join us on-demand: https://okt.to/YzbTxZ

The PASCAL laser, powered by Endpoint Management® technology, is a game-changer for patients suffering from Diabetic Macular Edema (DME). It significantly reduces the injection burden, making it a more comfortable treatment option. The clinical supplement sponsored by IRIDEX CORPORATION provides an in-depth insight into the treatment approach by Yannis M. Paulus, MD, FACS. Learn more about this innovative technology and the treatment approach by reading the clinical supplement. #PASCAL #EndpointManagement #DME #clinicalsupplement #IRIDEXCORPORATION

CroiValve yesterday presented favourable 6-month data from the TANDEM I first-in-human study of its novel Duo transcatheter tricuspid coaptation valve system for treating tricuspid regurgitation. The unique Duo system works in tandem with the native valve using a novel anchoring approach across the annulus. Key results showed: 📉 Significant TR reduction in ≥85% of patients 🚀 Improved quality of life 💯 100% survival, no arrhythmias/pacing issues  🎯 Successful device positioning/remodeling ⏱️ With a 43 minute average procedure time, the Duo system demonstrates early promise for treating tricuspid valve disease. 💪 CroiValve will continue evaluating this innovative therapy through additional clinical studies. #TTVR #MedTech #structuralheart #medicaldevices

Research is underway for #RSD #CRPS #CPS #Algoneurodystrophy, allowing you to be your best advocate for future diagnostics & treatments. If you are a patient interested in participating in a clinical trial, email [email protected] to join the list of interested patients